By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Molecular Devices will distribute ChanTest's portfolio of ion channel and GPCR cell lines under a non-exclusive deal announced today.

As part of the deal, Molecular Devices will also sell ChanTest's cell optimization services to Molecular Devices' customers worldwide using its PatchXpress 7000A, IonWorks Quattro, IonWorks Barracuda, and FLIPR Tetra systems.

Based in Cleveland, ChanTest has more than 145 ion channel and 110 GPCR cell lines

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.